Bausch + Lomb Corporation
NYSE:BLCOMedical - Instruments & Supplies
+$0.04 today
- Market cap
- $7.49B
- Beta
- 0.57
- P/E (TTM)
- -24.2
- EPS (TTM)
- -$0.62
Volume 0.51M
Average 0.46M
BLCO Total Liabilities
Everything the company owes to creditors and other parties.
Bausch + Lomb CorporationNYSE: BLCO
Total Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total liabilities broadly unchanged from a year ago
Total liabilities stood at $7.42B at the end of Q2 FY2026, up 1.2% from a year earlier and up 1.2% from the prior quarter. Over 3 fiscal years it compounded at +22.9% a year.
Context
- Total liabilities amounted to 53.5% of total assets at the end of Q2 FY2026, up 0.6 pp from a year earlier.
- Total liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +1.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 7.5B USD
- Year-over-year change
- +8.3%
- 4-year CAGR
- +51.6%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.5B | +8.3% |
| FY2024 | 2024-12-31 | 6.93B | +6.2% |
| FY2023 | 2023-12-31 | 6.52B | +61.3% |
| FY2022 | 2022-12-31 | 4.04B | +184.5% |
| FY2021 | 2021-12-31 | 1.42B | — |
Total Liabilities vs competitors
How BLCO compares with its peers on the latest reported figures
- BLCO's Jun 2026 total liabilities of $7.42B is the 2nd highest of the 10 companies compared; the peer median is $1.18B.
- Its year-over-year change of +1.2% is the lowest of 10, against a peer median of +62.5%.
- Total liabilities amounts to 53.5% of total assets for BLCO, versus a peer median of 60.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $9.17B | +75.6% | +13.7% | 81.7% | |
| Jun 2026 | $7.42B | +1.2% | +22.9% | 53.5% | |
| Jun 2026 | $3.88B | +23.9% | +9.6% | 57.2% | |
| Jun 2026 | $3.42B | +20.2% | +14.8% | 105.1% | |
| Sep 2026 | $1.69B | +91.4% | +52.2% | 97.1% | |
| Sep 2026 | $1.18B | +7.2% | +28.5% | — | |
| Sep 2026 | $1.02B | +144.2% | +45.4% | 64.1% | |
| Sep 2026 | $908.34M | +175.8% | -2.2% | 35.5% | |
| Jun 2026 | $380.21M | +62.5% | +90.0% | 12.1% | |
| Jun 2026 | $238.04M | +7.3% | -24.2% | 25.9% | |
| Peer median (excluding BLCO) | $1.18B | +62.5% | +14.8% | 60.6% | |
Competitors are the stored peer set for BLCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 174M | 380M | 334M | 305M | 383M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 721M | 726M | 875M | 1.03B | 1.22B |
| Inventory | 572M | 628M | 1.03B | 1.04B | 976M |
| Other Current Assets | 3M | 403M | 505M | 421M | 397M |
| Total Current Assets | 1.64B | 2.14B | 2.74B | 2.79B | 2.98B |
| Property, Plant & Equipment (Net) | 1.23B | 1.42B | 1.5B | 1.49B | 1.76B |
| Goodwill | 4.59B | 4.51B | 4.58B | 4.52B | 4.76B |
| Intangible Assets | 2.26B | 2.06B | 3.59B | 3.49B | 3.28B |
| Long-term Investments | 0 | 12M | 19M | 19M | 7M |
| Tax Assets | 933M | 927M | 921M | 885M | 934M |
| Other Non-current Assets | 180M | 84M | 92M | 275M | 303M |
| Total Non-current Assets | 9.19B | 9.01B | 10.7B | 10.68B | 11.05B |
| Total Assets | 10.82B | 11.14B | 13.44B | 13.47B | 14.02B |
| Account Payables | 239M | 317M | 522M | 389M | 388M |
| Short-term Debt | 28M | 51M | 57M | 40M | 77M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 356M | 732M | 709M | 459M | 1.46B |
| Total Current Liabilities | 1.1B | 1.3B | 1.58B | 1.74B | 1.92B |
| Long-term Debt | 0 | 2.41B | 4.53B | 4.74B | 5.17B |
| Deferred Tax Liabilities | 0 | 7M | 14M | 13M | 19M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 230M | 237M | 310M | 310M | 271M |
| Total Non-current Liabilities | 322M | 2.75B | 4.94B | 5.19B | 5.58B |
| Total Liabilities | 1.42B | 4.04B | 6.52B | 6.93B | 7.5B |
| Common Stock | 10.36B | 0 | 0 | 0 | 0 |
| Retained Earnings | 0 | 6M | (254M) | (571M) | (931M) |
| Accumulated OCI | (1.04B) | (1.26B) | (1.25B) | (1.39B) | (1.18B) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 73M | 68M | 70M | 71M | 71M |
| Total Equity | 9.4B | 7.1B | 6.92B | 6.54B | 6.52B |
| Total Debt | 140M | 2.55B | 4.68B | 4.94B | 5.37B |
| Net Debt | (34M) | 2.17B | 4.34B | 4.63B | 4.99B |
Bausch + Lomb Corporation
NYSE:BLCO
Intrinsic Alpha fair value
Locked
Current Price
$20.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.